glp-1 savings card The updated & GIP Meds PocketCard now feature two distinct versions— one for diabetes and one for weight management—each outlining maximum doses and indications to support individualized treatment decisions! Click here to RYBELSUS® (semaglutide) tablets 7 mg

Current research investigating potential advantages beyond glycaemic regulation and weight reduction, including impacts on non-alcoholic fatty liver disease, cardiovascular outcomes, and renal protection, may broaden the therapeutic uses of these medicines

Real-world results vary based on dose tolerance, adherence, nutrition, physical activity, medication access, side effects, sleep, alcohol intake, stress, medical history, and follow-up consistency

Neuroprotective actions of glucagon-like peptide-1 (GLP-1) analogues in alzheimers and parkinsons diseases

They were sued in August 2023 by a Louisiana woman Jaclyn Bjorklund, who alleged the companies downplayed the severity of the gastrointestinal events caused by Ozempic and Mounjaro, and in particular played down the risk of gastroparesis, which is the slowing or stopping of the digestive system

GLP-1 medications support weight loss by mimicking the action of a natural hormone in your body called glucagon-like peptide-1